Presentation is loading. Please wait.

Presentation is loading. Please wait.

Liver Ann Parasram 8th February 2010.

Similar presentations

Presentation on theme: "Liver Ann Parasram 8th February 2010."— Presentation transcript:

1 Liver Ann Parasram 8th February 2010

2 Liver Physiology What are LFT’s Role of LFT’s in investigation of Liver Disease Investigation of abnormal LFT Case studies

3 Major functions of liver
Carbohydrate Metabolism Fat Metabolism Protein Metabolism Hormone Metabolism Removal of endogenous and exogenous waste products Storage Metabolism and excretion of bilirubin

4 Liver Physiology 6 segments, each with own branch of hepatic artery, portal vein and bile duct Metabolic activity occurs within parenchymal cells.80% of organ mass Remarkable reserve and Ig functional reserve

5 Bilirubin Metabolism

6 What are LFT’s? No standard LFT profile Basildon use – -Total protein
- Albumin - Total Bilirubin - Alkaline phosphatase (ALP) - Alanine aminotransferase (ALT) Do standard ‘LFT’ assess liver capacity to perform normal function

7 What are LFT’s? Other biochemical LFT options Total protein
Conjugated bilirubin Gamma glutamyl transferase (GGT) Aspartate aminotransferase (AST)

8 Normal Ranges Total Protein 60 – 80g/l Total Bilirubin <20µmol/l
ALT 5 – 40IU/l ALP 30 – 130IU/l Albumin – 50g/l

9 Laboratory Investigations
Diagnosis Prognosis Monitoring Screening No single lab test currently exists which: Provides answers to the above Provides a quantitative assessment of functioning liver capacity Use of combination of standard LFT’s and serial monitoring enhances clinical utility

10 Aminotransferase ALT and AST Intracellular enzymes
↑ plasma enzymes activity due to leakage from damaged or necrotic hepatocytes Not liver specific – wide tissue distribution, heart, muscle Plasma activities of AST and ALT are sensitive indicators of hepatocyte damage due to toxins and viruses but are not specific for liver pathology

11 AST - 2 genetically distinct isoenzymes exist; mitochondrial AST (80%) and cystolic AST (20%) - Mild tissue injury results in predominately cystolic release ALT - cystolic enzymes - shows greater liver specificity than AST - Majority of liver disease ALT elevated to a greater degree

12 Abnormal ALT in asymptomatic patients
Is it abnormal? Alcohol abuse (GT useful) Drugs Antibiotics - penicillins, ciprofloxacin etc. AED’s - phenytoin, carbamazepine Statins NSAID’s Sulphonylureas - glipizide Herbs, homeopathic Rx - ephedra, senna Drugs of abuse - steroids, cocaine, MDMA, glues

13 Abnormal ALT in asymptomatic patients
Chronic hepatitis hepatitis C, B Autoimmune hepatitis raised globulin (80%) on electrophoresis auto-antibody tests (ANA) Haemochromatosis transferrin saturation (>45%) Coeliac disease Wilson’s disease (<40 yrs) caeruloplasmin (85%), Kaiser-Fleischer rings Alpha1-antitrypsin deficiency

14 Alkaline Phosphatase Membrane bound enzyme
Family of isoenzymes and isoforms Present in many tissues

15 Alkaline Phosphatase Plasma ALP levels are increased further by the solubilisation of membrane bound enzyme due to the detergent action of bile acids Plasma ALP is a sensitive indicator of Choleostasis but is non-specific for liver pathology

16 Alkaline Phosphatase Produced by the biliary tract at all levels from the canalculi to the mucosa of the gall bladder Involved in metabolic transport across cell membrane Obstruction to bile flow or secretion results in enzyme induction with increased mucosal synthesis of ALP

17 Alkaline Phosphatase Liver or bone? (pregnancy, adolescence)
GT useful to exclude liver Age related changes increase (particularly women) between 40 and 65 yrs If persistent raised ALP of liver origin Primary biliary cirrhosis anti-mitochrondrial antibodies Ultrasonography

18 GT – Gamma Glutamyl Transferase
Membrane bound, wide tissue distribution; liver, kidney and pancreas Elevated plasma activity results from solubilisation of bound enzyme by bile salts, cell necrosis and altered membrane permeability Slightly more sensitive than ALP in Obstructive Liver Disease

19 GT Synthesis induced by drugs such as DPH, BARBS, Tricyclics and ETOH in absence of liver pathology Sensitive indicator of liver disease but will differ hepatocellular from choleostatic disease An increase GT activity can confirm an increase ALP activity as being liver in origin

20 GT Very sensitive for hepatobiliary disease Poor specificity
pancreatic disease, AMI, renal failure, diabetes, COPD, alcoholism Alcohol abuse – poor marker Reported sensitivity % Best used to evaluate rises in other LFT’s

21 Albumin Index of hepatic synthetic function
Low ALB often accompanies chronic liver disease May not indicate reduced synthesis

22 Albumin Plasma ALB also affected by nutritional stasis, leakage into ascites, renal losses and dilation due to fluid retention Prothrombin better indicator as shorter ½ life Normal ALB is good indicator of adequate synthetic function in chronic liver disease

23 Bilirubin Specific for liver dysfunction
Assessment of hepatic anion transport Insensitive due to large hepatic functional reserve Normally 92% of bili unconjugated Raised bili due to increased production, impaired metabolism or reduced excretion

24 Bilirubin Plasma bilirubin levels >50µmol/l detected clinically as jaundiced Bilirubinuria is always conjugated and is always pathological

25 Typical patterns of abnormalities of simple LFT in various liver diseases.
Condition Acute Chronic Cirrhosis Choleostasis Malignancy Hepatitis Hepatitis or Test Infiltration Bilirubin N to ↑↑ N to ↑ N to ↑ ↑ to ↑↑↑ N Aminotransferase ↑↑↑ ↑ N to ↑ N to ↑ N to ↑ Alkaline Phosphatase N to ↑↑ N§ N to ↑↑ ↑↑↑ ↑↑ Albumin N N to ↓ N to ↓ N N to ↓ -Globulins N ↑ ↑ N N Prothrombin Time N to ↑* N to ↑ N to ↑* N to↑† N N = Normal *Not corrected by parental Vitamin K § May be increased if Cirrhosis present †Corrected by parental Vitamin K

26 Miscellaneous tests of Liver Disease
Plasma Bile Acids – highly specific indicator of hepatic anion transport, technically demanding Immunoglobulins – Generally increased in chronic disease. IgM greatly increased in Primary biliary cirrhosis. IgG in autoimmune chronic active hepatitis α-fetoprotein – Increased in 70% of primary hepatocellular carcinomas

27 Role of LFT’s in the Investigation of Liver Disease
A )Diagnosis Poor diagnostic tool Non-specific, cannot quantitate extent of liver damage Imaging, Clinical history and histology better Cheap, non-invasive, automated, can direct further investigation

28 Role of LFT’s in the Investigation of Liver Disease
Surgical v’s non-surgical jaundice Raised Bilirubin in range 20 – 100µmol/l with other LFT’s normal Haemolytic jaundice or Gilberts rather than extrahepatic biliary dysfunction

29 Role of LFT’s in the Investigation of Liver Disease
Hepatocellular v’s Choleostasis Raised Bili, ALP and GT with normal or slightly raised ALT Indicates Choleostasis (but cannot distinguish intra from extrahepatic)

30 Typical Biochemical Changes during Acute Hepatitis
Role of LFT’s in the Investigation of Liver Disease B) Monitoring – Main role of LFT Typical Biochemical Changes during Acute Hepatitis Pre – icteric Icteric Plasma bilirubin Plasma aminotransferase Plasma alkaline phosphatase Urinary bilirubin Urinary urobilogen N/↑ ↑↑↑ N ↑↑ absent Typical biochemical changes during acute hepatitis

31 Role of LFT’s in the Investigation of Liver Disease
Causes of Acute Viral hepatitis Pre icteric – ALT/AST raised; other LFT normal Icteric – AST/ALT peak; 6 – 100 ULN Normally ALT>AST AST>ALT poor prognosis ALP normal/slightly raised (unless choleostatic element).

32 Role of LFT’s in the Investigation of Liver Disease
Enzyme levels can be expected to return to normal in about 5 weeks Persistently raised levels (3 x ULN) could indicate chronic persistent hepatitis Sudden reduction in aminotransferase activity bad sign indicating fulminant liver function

33 Role of LFT’s in the Investigation of Liver Disease
Neonatal raised Bilirubin Need accurate measure of Bilirubin at critical levels (age, weight and ALB dependant) Phototherapy > 200µmol/l Exchange transfusion >3

34 Role of LFT’s in the Investigation of Liver Disease
Autoimmune Chronic Hepatitis Therapy - Successful immunosuppressant indicated by reduced AST activity. Relapse indicated by raised ALP activity Post-op Obstructive Jaundice - Clearance of obstructive jaundiced followed by serial bilirubin measurement

35 Role of LFT’s in the Investigation of Liver Disease
Cirrhosis - No reliable test for compensated cirrhosis - Procollagen Type III peptide. Non-invasive marker for fibrosis but it is non-specific

36 Role of LFT’s in the Investigation of Liver Disease
Alcoholic Liver Disease GT induced by ETOH If raised as a result ETOH intake may never return to normal Liver Transplant Std LFT used to monitor rejection Raised Bilbirubin increased when rejection occurs

37 Role of LFT’s in the Investigation of Liver Disease
C) Prognosis Limited role Pre-transplant assessment of end stage liver disease Primary Biliary Cirrhosis - raised bili .....poor sign......<2yr survival bili >120µmol/l Fulminant hepatic failure - bili >300µmol/l, poor prognostic sign

38 New Generation LFT Need cheap, reliable, convenient test:
‘accurately diagnose liver pathology’ ‘provide a quantitative assessment of functional hepatic mass’

39 New Generation LFT Quantitative LFT but are complex and limited to specific centres Aminopyrine Breath Test, measures Cyto P450 (dependent demethylation of Carbon 14 labelled aminopyrine to Carbon Dioxide) Indocyanine green clearance – asses hepatic blood flow and hepatocellular activity.

40 New Generation LFT Hepatocellular damage – glutathione-5-transferase, molecule sensitive to AST/ALT. Evenly distributed throughout liver, half-life 90 minutes, early marker of liver injury Choleostasis – CA19-9, Increased serum level due to biliary clearance

41 Investigation of abnormal LFTs
Causes of liver disease

42 Liver Pathology Hepatitis – Inflammation and cell damage
Toxins, metabolites, infections, autoantibodies Cirrhosis – fibrosis infiltration, shrinkage Tumours (Carcinoma) Primary or Secondary metastases Obstruction (Choleostasis) - failure of secretion of bile e.g. Chronic hepatitis cirrhosis years Gold Std – Imaging and endoscopy

43 Hepatitis Viral or toxic Acute or chronic
Viral Agents: Hep A B C (D + E) CMV, EBV Toxic Agents: Paracetamol, Alcohol Acute Disease: < 6 months duration Chronic Disease: > 6 months with non resolution of acute

44 Outcome of Hepatitis Majority of hepatitis cases result in complete resolution Minority will develop fulmanant hepatic failure All forms of acute hepatitis may develop into chronic disease except Hep A Chronic hepatitis may be classified by histology - Chronic persistent hepatitis (benign) Chronic acute hepatitis (histological distinct) Chronic disease can progress to Cirrhosis, can progress to Carcinoma

45 Case History 1 A 20 year old student developed a flu-like illness with a loss of appetite, nausea and pain in the right hypochondrium. On examination, the liver was just palpable and was tender. Two weeks later he developed jaundice, his urine became darker in colour and his stool became pale.

46 Case History -1 Investigations Serum: bilirubin 38µmol/l 230µmol/l
on presentation one week later Serum: bilirubin 38µmol/l 230µmol/l albumin 40g/l g/l AST U/l 365U/l ALP 70IU/l 150IU/l GGT 60U/l 135U/l Urine: bilirubin positive positive urobilinogen positive negative

47 Cirrhosis Aetiology – autoimmune, chronic viral, alcohol Inherited, metabolic disease or Primary cirrhosis Diagnosed by demonstration of fibrous and architectural disruption in biopsy specimen Irreversible No symptoms whilst compensated due to functional reserve Symptoms manifest after decompensation – haematemesis, ascites, portal hypertension, encephalopathy, coma

48 Case History 2 A middle aged female was admitted to hospital following a haematemesis. Endscopy revealed the presence of oesophageal varices. The only biochemical abnormality was an elevated GGT (245IU/L). The patient was told to abstain from alcohol. She was admitted one year later, jaundiced, drowsy and with clinical signs of liver disease.

49 Case History - 2 Investigations Serum: Albumin 25g/l Bilirubin 260µmol/l ALP 315U/l AST 134U/l GGT 360U/l

50 Hepatocellular Carcinoma (HCC)
Only 2% of all Cancers in the UK Significant problem worldwide (Hep B, C; Haemachromatosis) 80% due to Cirrhosis 5yr Survival rate – 15% Imaging used to identify tumour, biopsy Inappropriate and surgical resection is only treatment

51 Case History 3 A elderly woman, weight loss and constipation.
She has lost approx 8kg in weight in 2 months and had lost her appetite . She had previously opened her bowels daily but had recently had several days between movements and had passed a small amount on each occasion. On examination she was anaemic and had obviously lost weight . The liver was enlarged and had an irregular edge, a mass was palpable in the right iliac fossa

52 Case History – 3 Serum: Albumin 30g/l ALP 314U/l
Bilirubin, AST and GGT normal Stool Occult Blood positive A barium enema revealed a carcinoma of the caecum; an isotopic liver scan showed multiple filing defects characteristic of tumour deposits

53 Choleostasis Intrahepatic – Bile secretion from the hepatocytes into the canaliculi is impaired Extrahepatic - due to obstruction to the flow of performed bile through the biliary tract Symptoms; Pruritis, jaundice, pale stools and dark urine Intra – due to viral hep/ drugs – chlorpromazine or toxins – ETOH Inflammation of the biliary tract (Cholangitis) Autoimmune disease – Primary biliary cirrhosis (destruction of bile duct due by lymphatic invasion leading to cirrhosis CF Extra – biliary stones/ inflamation of biliary tract

54 Case History 4 A 40 yr old women presented with jaundice.
There was no history of contact with hepatitis, recent foreign travel, injections or transfusions. She did not drink alcohol. She had been well in the past but had suffered pruritus during the past 18months.

55 Case Study - 4 Investigations Serum: Total Protein 85g/l Albumin 28g/l Bilirubin 340µmol/l ALP 522U/l AST 98U/l GGT 242U/l

56 Gilbert’s Syndrome – inherited disorder of bilirubin metabolism
Asymptomatic, episodes of raised bilirubin Especially if fasting, tired, other illness Common, up to 5% - male > female Hyperbilirubinaemia <100 umol/l All other biochemical LFT’s normal Unconjugated hyperbilirubinaemia Prolonged fasting (45hrs): 2-3 fold increase Nicotinic acid (I.v. 50mg): 2-3 fold increase

57 Case History - 5 A medical student recovering from an attack of influenza was noticed to be slightly jaundiced. Worried that he might have hepatitis, the student had some blood taken for biochemical tests.

58 Case Study – 5 Serum Bilirubin 60umol/l ALP 74 U/l AST 35 U/l Hb 16g/dl Retics 1% Urine bilirubin Neg

59 Inherited disorder of bilirubin metabolism
Include; Crigler-Najjar Dublin-Johnson Rotor

Download ppt "Liver Ann Parasram 8th February 2010."

Similar presentations

Ads by Google